Get 50% OFF This Monsoon!

Advertisement
AdvertisementAdvertisement
logo

Hemant Surgical Industries

543916
Micro Cap
(%) 1D
no_data

No Data Available

1D1W1M3M6M1YMAX

Investor Sentiment

50%50%
Bullish
Bearish
Advertisement
AdvertisementAdvertisement

Hemant Surgical Industries Share price and Fundamental Analysis

View All Details
View All Details
Hemant Surgical Industries Ltd was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Maharashtra, Mumbai. Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai.
Company Incorporation1989
ChairmanHANSKUMAR SHAMJI SHAH
Head QuartersNA
Previous NameNA

Key Metrics

Market Cap (Cr)
101.37
PE Ratio
12.61
Industry P/E
36.42
PEG Ratio
0
ROE
12.73%
ROCE
13.45%
ROA
5.42%
Total Debt (Cr)
30.84
Debt to Equity
0.49
Dividend Yield
0%
EPS
7.7
Book Value & P/B
60.34 x 1.61
Face Value
10
Outstanding Shares(Cr)
1.04
Current Ratio
1.66
EV to Sales
1.15

Stock Returns

1 Week+4.97%
1 Month-10.05%
6 Months-25.31%
1 Year-33.83%
3 Years-45.92%
5 Years-45.92%

CAGR

1 Year CAGR

Revenue Growth

-3.24%

Net Profit Growth

+28.08%

Operating Profit Growth

+15.29%

Dividend Growth

N/A

Stock Returns CAGR

-32.69%
no_data

No Stocks

Smart Score

2.1
icn

Unlock Smart Score

See Detailed Analysis & Insights

icn

Unlock Insights

See Detailed Analysis & Insights

Technicals

Returns Calculator

If you would have invested
In 5 years the current value would be
NaNCRNaNCR( %)

Research Report

No Research Report

View Other Reports >

Corporate Action

Board-Meetings
Board-Meetings
Dividends
Bonus
Splits
Right-issues
AGM-EGM
Bulk-Deal
Block-Deal

Financials

Half Yearly Statement

PARTICULARS

Total Revenue

Total Expenses

Operating Expense

Operating Profit

Interest

Depreciation & Amortization

Profit Before Tax

Tax

Profit after tax

Adj EPS in Rs - Basic

Adj EPS in Rs - Diluted

Profit and Loss Statement

Credit Rating
Director Report
Chairman Report
Auditor Report
Mar 25

Promoters : 73.56%

FIIs : 0.39%

DIIs : 1.11%

Public : 24.93%

Promoter
FII/FPI
DII
Public
Promoter Pledge stands at 0.0% of holding in March 2025 Qtr
FII Shareholding Increased by 0.39% to 0.39% in March 2025 Qtr
DII Shareholding Decreased by 0.02% to 1.11% in March 2025 Qtr

Top Shareholders

View all Share Holders

Key Ratios

Profitability
Valuation
Liquidity

ROE

Avg ROE (3 Yrs) : NaN%

ROCE

Avg ROCE (3 Yrs) : NaN%

ROA

Avg ROA (3 Yrs) : NaN%

NPM

Avg NPM (3 Yrs) : NaN%

Dividend History

Hemant Surgical Industries Competitors

Sector
Industry

Company Name

MCap(TTM)

PE(TTM)

P/B(TTM)

ROE(TTM)

D/E

Current Ratio(TTM)

5 Year FactSheet

Profitability
Profitability
Growth Ratios
Valuation Ratios
Cashflow Ratios
Debt and Liquidity
Efficiency Ratios

Documents

Annual Reports
Con-Call

News

Hemant Surgical Industries Management and History

Company Management

icn

Unlock Management Data

See Detailed Analysis & Insights

Company History

Hemant Surgical Industries Ltd was originally incorporated as 'Hemant Surgical Industries Private Limited' dated March 27, 1989, by ROC, Maharashtra, Mumbai. Subsequently, Company was converted into a public limited company and the name of Company was changed to 'Hemant Surgical Industries Limited' vide fresh Certificate of Incorporation dated February 22, 1994 by the Registrar of Companies, Mumbai.

The Company manufacture, import, assemble and market a comprehensive portfolio of medical equipments and disposables. Its product offerings cover a wide spectrum of equipments and disposables required for Renal Care, Cardiovascular Disease, Respiratory Disease, Critical Care and Radiology and Surgical disposables. In addition, the Company is providing services for maintenance and in running of dialysis centres.

The Company started its operations in 1993 with importing and marketing of medical disposables like meditapes, all over India from JMS Co Ltd. Japan. Later in year 1999, it started the operations by expanding manufacturing plant at Achhad, Maharashtra and is currently manufacturing products like Dialysis solution (liquid and Powder) used in dialysis, Hot and Cold Sterilant used for cleaning dialyzer, Purified water used in rinsing and cleaning of dialysis machines and sanitizer.

Assembly Unit II situated at Atgaon is used in various medical devices like Nebulizers, Oxygen Concentrator, Air Mattress, Digital Thermometer, Pulse Oximeters, ECG Electrodes, Dialyzer which are sold under the Brand Name 'Aero Plus'. Assembly Unit III at Bhiwandi is used in products like Intravenous Infusion Set, ECG Machines, Ultrasound Machines, Paramonitor, Ventilator etc.

Later, in year 2022, the Company got into a distribution agreement with JMS Co. Ltd., Japan for importing and marketing JMS Meditape in India, with JMS Singapore Pte. Ltd. for manufacturing Intravenous Infusion Set. The Company was appointed as sole agent of SWS Hemodialysis Care Co. Ltd. China to sell and do maintenance of SWS-4000A hemodialysis machines in West India. It signed distribution agreement with Hemant Phillipines Inc. for supply in renal care equipment, medical devices and consumables for marketing the same in Philippines, with Zoncare Bio-medical Electronics Co., Ltd for radiology and assembly of critical care products like Ultrasound Machine.

The Company is planning to come out with an initial public offer consisting of issuing upto 27,60,000 Equity Shares.

Hemant Surgical Industries Share Price

Hemant Surgical Industries share price reflects investor sentiment toward the company and is impacted by various factors such as financial performance, market trends, and economic conditions. Share price is an indicator which shows the current value of the company's shares at which buyers or sellers can transact.

Hemant Surgical Industries Market Cap

Market capitalization of Hemant Surgical Industries indicates the total value of its outstanding shares. Marketcap is calculated by multiplying share price and outstanding shares of the company. It is a helpful metric for assessing the company's size and market Valuation. It also helps investors understand how Hemant Surgical Industries is valued compared to its competitors.

Hemant Surgical Industries PE Ratio

Hemant Surgical Industries PE ratio helps investors understand what is the market value of each stock compared to Hemant Surgical Industries 's earnings. A PE ratio higher than the average industry PE could indicate an overvaluation of the stock, whereas a lower PE compared to the average industry PE could indicate an undervaluation.

Hemant Surgical Industries PEG Ratio

The PEG ratio of Hemant Surgical Industries evaluates its PE ratio in relation to its growth rate. A PEG ratio of 1 indicates a fair value, a PEG ratio of less than 1 indicates undervaluation, and a PEG ratio of more than 1 indicates overvaluation.

Hemant Surgical Industries ROE (Return on Equity)

Return on Equity (ROE) measures how effectively Hemant Surgical Industries generates profit from shareholders' equity. A higher ROE of more than 20% indicates better financial performance in terms of profitability.

Hemant Surgical Industries ROCE (Return on Capital Employed)

Return on Capital Employed (ROCE) evaluates the profitability of Hemant Surgical Industries in relation to its capital employed. In simple terms, ROCE provides insight to investors as to how well the company is utilizing the capital deployed. A high ROCE of more than 20% shows that the business is making profitable use of its capital.

Hemant Surgical Industries Total Debt

Total debt of Hemant Surgical Industries shows how much the company owes to either banks or individual creditors. In simple terms, this is the amount the company has to repay. Total debt can be a very useful metric to show the financial health of the company. Total debt more than equity is considered to be a bad sign.

Hemant Surgical Industries Debt to Equity Ratio

The Debt-to-Equity (DE) ratio of Hemant Surgical Industries compares its total debt to shareholders' equity. A higher Debt to Equity ratio could indicate higher financial risk, while a lower ratio suggests that the company is managing its debt efficiently.

Hemant Surgical Industries CAGR (Compound Annual Growth Rate)

CAGR shows the consistent growth rate of Hemant Surgical Industries over a specific period, whether it is over a month, a year, or 10 years. It is a key metric to evaluate the company’s long-term growth potential. Main metrics for which CAGR is calculated are net sales, net profit, operating profit, and stock returns.

Hemant Surgical Industries Technical Analysis

Technical analysis of Hemant Surgical Industries helps investors get an insight into when they can enter or exit the stock. Key components of Hemant Surgical Industries Technical Analysis include:

Support Levels (S1, S2, S3)

There are usually multiple support levels, but the main support levels for a stock are S1, S2, S3. Support levels indicate price points where stock might get support from buyers, helping the stock stop falling and rise.

Resistance Levels (R1, R2, R3)

There are usually multiple resistance levels, but the main resistance levels for a stock are R1, R2, R3. Resistance levels represent price points where Hemant Surgical Industries shares often struggle to rise above due to selling pressure.

Hemant Surgical Industries Dividends

Dividends refer to the portion of the company’s profits distributed to its shareholders. Dividends are typically paid out in cash and reflect Hemant Surgical Industries ’s financial health and profitability.

Hemant Surgical Industries Bonus Shares

Bonus shares are usually given by companies to make the stock more affordable, increase liquidity, boost investor confidence, and more.

Hemant Surgical Industries Stock Split

Stock split increases the number of its outstanding shares by dividing each existing share into multiple shares. When the company offers a stock split, the face value of the stock reduces in the same proportion as the split ratio.

Hemant Surgical Industries Financials

The financials of Hemant Surgical Industries provide a complete view to investors about its net sales, net profit, operating profits, expenses, and overall financial health. Investors can analyze financial data to assess the company’s stability and also understand how the company has been growing financially.

Hemant Surgical Industries Profit and Loss Statements

The profit and loss statement of Hemant Surgical Industries highlights its net sales, net profit, total expenditure, and operating profits in the current financial year. This Profit and Loss statement is crucial for evaluating the profitability and financial stability of Hemant Surgical Industries .

Hemant Surgical Industries Balance Sheet

The balance sheet presents a snapshot of Hemant Surgical Industries ’s assets, liabilities, and equity of shareholders, providing insights into the financials of the company.

Hemant Surgical Industries Cashflow Statements

Cashflow statements track the company's cash inflows and outflows over a period. It is an essential tool for understanding how well the company manages its liquidity and finances.

Download the App

Download the App